Impact of the pan-Canadian Oncology Drug Review on provincial concordance with respect to cancer drug funding decisions and time to funding

BACKGROUND: The pan-Canadian Oncology Drug Review (pcodr) was implemented in 2011 to address uneven drug coverage and lack of transparency with respect to the various provincial cancer drug review processes in Canada. We evaluated the impact of the pcodr on provincial decision concordance and time f...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Curr Oncol
Auteurs principaux: Srikanthan, A., Mai, H., Penner, N., Amir, E., Laupacis, A., Sabharwal, M., Chan, K.K.W.
Format: Artigo
Langue:Inglês
Publié: Multimed Inc. 2017
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5659150/
https://ncbi.nlm.nih.gov/pubmed/29089796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.24.3648
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires